These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27182657)

  • 1. Functional mesoporous silica nanoparticles (MSNs) for highly controllable drug release and synergistic therapy.
    Cheng YJ; Zeng X; Cheng DB; Xu XD; Zhang XZ; Zhuo RX; He F
    Colloids Surf B Biointerfaces; 2016 Sep; 145():217-225. PubMed ID: 27182657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
    Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
    ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery.
    Naz S; Wang M; Han Y; Hu B; Teng L; Zhou J; Zhang H; Chen J
    Int J Nanomedicine; 2019; 14():2533-2542. PubMed ID: 31114189
    [No Abstract]   [Full Text] [Related]  

  • 5. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.
    Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH
    Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
    Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
    Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional Mesoporous Silica Nanoparticles Based on Charge-Reversal Plug-Gate Nanovalves and Acid-Decomposable ZnO Quantum Dots for Intracellular Drug Delivery.
    Zhang J; Wu D; Li MF; Feng J
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26666-73. PubMed ID: 26553405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
    Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
    Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-Cell-Specific Nuclear-Targeted Drug Delivery by Dual-Ligand-Modified Mesoporous Silica Nanoparticles.
    Xiong L; Du X; Kleitz F; Qiao SZ
    Small; 2015 Nov; 11(44):5919-26. PubMed ID: 26426251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ monitoring of intracellular controlled drug release from mesoporous silica nanoparticles coated with pH-responsive charge-reversal polymer.
    Zhang P; Wu T; Kong JL
    ACS Appl Mater Interfaces; 2014 Oct; 6(20):17446-53. PubMed ID: 25231082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging.
    Shanta Singh N; Kulkarni H; Pradhan L; Bahadur D
    Nanotechnology; 2013 Feb; 24(6):065101. PubMed ID: 23324398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A redox-responsive mesoporous silica nanoparticle with a therapeutic peptide shell for tumor targeting synergistic therapy.
    Xiao D; Hu JJ; Zhu JY; Wang SB; Zhuo RX; Zhang XZ
    Nanoscale; 2016 Sep; 8(37):16702-16709. PubMed ID: 27714082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
    Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
    Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graphene Quantum Dots-Capped Magnetic Mesoporous Silica Nanoparticles as a Multifunctional Platform for Controlled Drug Delivery, Magnetic Hyperthermia, and Photothermal Therapy.
    Yao X; Niu X; Ma K; Huang P; Grothe J; Kaskel S; Zhu Y
    Small; 2017 Jan; 13(2):. PubMed ID: 27735129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-responsive mesoporous silica nanoparticles to generation of hydrogen peroxide for synergistic cancer starvation and chemistry therapy.
    Du X; Zhang T; Ma G; Gu X; Wang G; Li J
    Int J Nanomedicine; 2019; 14():2233-2251. PubMed ID: 31118604
    [No Abstract]   [Full Text] [Related]  

  • 19. Gated magnetic mesoporous silica nanoparticles for intracellular enzyme-triggered drug delivery.
    An N; Lin H; Yang C; Zhang T; Tong R; Chen Y; Qu F
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():292-300. PubMed ID: 27612716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
    Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N
    Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.